
### [NCIT:C9251](http://purl.obolibrary.org/obo/NCIT_C9251)
**Label:** Recurrent Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C5008](http://purl.obolibrary.org/obo/NCIT_C5008) (Recurrent Burkitt Lymphoma), [NCIT:C115439](http://purl.obolibrary.org/obo/NCIT_C115439) (Recurrent Mycosis Fungoides and Sezary Syndrome), [NCIT:C4998](http://purl.obolibrary.org/obo/NCIT_C4998) (Recurrent Nodal Marginal Zone Lymphoma), [NCIT:C7805](http://purl.obolibrary.org/obo/NCIT_C7805) (Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C5026](http://purl.obolibrary.org/obo/NCIT_C5026) (Recurrent Nasal Type NK/T-Cell Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5007](http://purl.obolibrary.org/obo/NCIT_C5007) (Recurrent Follicular Lymphoma), [NCIT:C8852](http://purl.obolibrary.org/obo/NCIT_C8852) (Recurrent Diffuse Large B-Cell Lymphoma), [NCIT:C8676](http://purl.obolibrary.org/obo/NCIT_C8676) (Recurrent Angioimmunoblastic T-cell Lymphoma), [NCIT:C8874](http://purl.obolibrary.org/obo/NCIT_C8874) (Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8159](http://purl.obolibrary.org/obo/NCIT_C8159) (Recurrent Adult Burkitt Lymphoma), [NCIT:C5089](http://purl.obolibrary.org/obo/NCIT_C5089) (Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8158](http://purl.obolibrary.org/obo/NCIT_C8158) (Recurrent Grade 3 Follicular Lymphoma), [NCIT:C8155](http://purl.obolibrary.org/obo/NCIT_C8155) (Recurrent Grade 1 Follicular Lymphoma), [NCIT:C9189](http://purl.obolibrary.org/obo/NCIT_C9189) (Recurrent Childhood Burkitt Lymphoma), [NCIT:C8156](http://purl.obolibrary.org/obo/NCIT_C8156) (Recurrent Grade 2 Follicular Lymphoma), [NCIT:C8098](http://purl.obolibrary.org/obo/NCIT_C8098) (Recurrent Adult Non-Hodgkin Lymphoma), [NCIT:C8154](http://purl.obolibrary.org/obo/NCIT_C8154) (Recurrent Small Lymphocytic Lymphoma), [NCIT:C8680](http://purl.obolibrary.org/obo/NCIT_C8680) (Recurrent Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8163](http://purl.obolibrary.org/obo/NCIT_C8163) (Recurrent Adult Immunoblastic Lymphoma), [NCIT:C9250](http://purl.obolibrary.org/obo/NCIT_C9250) (Recurrent Anaplastic Large Cell Lymphoma), [NCIT:C69144](http://purl.obolibrary.org/obo/NCIT_C69144) (Recurrent Grade III Lymphomatoid Granulomatosis), [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8869](http://purl.obolibrary.org/obo/NCIT_C8869) (Recurrent B Lymphoblastic Lymphoma), [NCIT:C115349](http://purl.obolibrary.org/obo/NCIT_C115349) (Recurrent Adult Grade III Lymphomatoid Granulomatosis), [NCIT:C138027](http://purl.obolibrary.org/obo/NCIT_C138027) (Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C115369](http://purl.obolibrary.org/obo/NCIT_C115369) (Recurrent Childhood Non-Hodgkin Lymphoma), [NCIT:C8604](http://purl.obolibrary.org/obo/NCIT_C8604) (Recurrent Lymphoplasmacytic Lymphoma), [NCIT:C115367](http://purl.obolibrary.org/obo/NCIT_C115367) (Recurrent Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C8489](http://purl.obolibrary.org/obo/NCIT_C8489) (Recurrent Mantle Cell Lymphoma), [NCIT:C8841](http://purl.obolibrary.org/obo/NCIT_C8841) (Recurrent B-Cell Non-Hodgkin Lymphoma), [NCIT:C8688](http://purl.obolibrary.org/obo/NCIT_C8688) (Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C8663](http://purl.obolibrary.org/obo/NCIT_C8663) (Recurrent T-Cell Non-Hodgkin Lymphoma), [NCIT:C138025](http://purl.obolibrary.org/obo/NCIT_C138025) (Recurrent Intravascular Large B-Cell Lymphoma), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), [NCIT:C8488](http://purl.obolibrary.org/obo/NCIT_C8488) (Recurrent Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C5095](http://purl.obolibrary.org/obo/NCIT_C5095) (Recurrent Splenic Marginal Zone Lymphoma), [NCIT:C8164](http://purl.obolibrary.org/obo/NCIT_C8164) (Recurrent Adult Lymphoblastic Lymphoma), [NCIT:C8490](http://purl.obolibrary.org/obo/NCIT_C8490) (Recurrent Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C9060](http://purl.obolibrary.org/obo/NCIT_C9060) (Recurrent Childhood Lymphoblastic Lymphoma), [NCIT:C68684](http://purl.obolibrary.org/obo/NCIT_C68684) (Recurrent Marginal Zone Lymphoma), [NCIT:C127840](http://purl.obolibrary.org/obo/NCIT_C127840) (Recurrent Waldenstrom Macroglobulinemia), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 39.90%


